Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 5, 2013, Pages

  Patinha, Daniela ^a,b   Fasching, Angelica ^a   Pinho, Dora ^b,c   Albino Teixeira, António ^b   Morato, Manuela ^b,c   Palm, Fredrik ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Diabetes; Tubular function

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR; ANGIOTENSIN II; CANDESARTAN; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE RESPONSE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY MASS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE FUNCTION; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STREPTOZOCIN DIABETES; URINE FLOW RATE;

EID: 84874609706     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00285.2012     Document Type: Article

References (58)

1. Aki Y, Tomohiro A, Nishiyama A, Kiyomoto K, Kimura S, Abe Y. Effects of KW-3902, a selective and potent adenosine A1 receptor antagonist, on renal hemodynamics and urine formation in anesthetized dogs. Pharmacology 55: 193-201, 1997.
2. Albino-Teixeira A, Matias A, Polonia J, Azevedo I. Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J Hypertens Suppl 9: S196-197, 1991.
3. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 26, Suppl 1: S33-50, 2003.
4. Awad AS, Webb RL, Carey RM, Siragy HM. Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade. J Hypertens 22: 1571-1577, 2004.
5. Barrett RJ, Droppleman DA. Interactions of adenosine A1 receptormediated renal vasoconstriction with endogenous nitric oxide and ANG II. Am J Physiol Renal Fluid Electrolyte Physiol 265: F651-F659, 1993.
6. Burnier M, Brunner HR. Angiotensin II receptor antagonists in hypertension. Kidney Int Suppl 68: S107-111, 1998.
7. Carmines PK. The renal vascular response to diabetes. Curr Opin Nephrol Hypertens 19: 85-90, 2010.
8. Carmines PK, Morrison TK, Navar LG. Angiotensin II effects on microvascular diameters of in vitro blood-perfused juxtamedullary nephrons. Am J Physiol Renal Fluid Electrolyte Physiol 251: F610-F618, 1986.
9. Fransen R, Boer WH, Boer P, Dorhout Mees EJ, Koomans HA. Effects of furosemide or acetazolamide infusion on renal handling of lithium: a micropuncture study in rats. Am J Physiol Regul Integr Comp Physiol 264: R129-R134, 1993.
10. Griffin KA, Abu-Naser M, Abu-Amarah I, Picken M, Williamson GA, Bidani AK. Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes. Am J Physiol Renal Physiol 293: F1605-F1613, 2007.
11. +-ATPase activity via a NO/cGMP-dependent pathway. Am J Physiol Renal Physiol 290: F1430-F1436, 2006.
12. Hall JE, Granger JP, Hester RL. Interactions between adenosine and angiotensin II in controlling glomerular filtration. Am J Physiol Renal Fluid Electrolyte Physiol 248: F340-F346, 1985.
13. Hannedouche TP, Delgado AG, Gnionsahe DA, Boitard C, Lacour B, Grunfeld JP. Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int 37: 1126-1133, 1990.
14. Hayashi K, Epstein M, Loutzenhiser R, Forster H. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol 2: 1578-1586, 1992.
15. Jackson EK. Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol 31: 1-35, 1991.
16. Kirchner KA. Lithium as a marker for proximal tubular delivery during low salt intake and diuretic infusion. Am J Physiol Renal Fluid Electrolyte Physiol 253: F188-F196, 1987.
17. Knight RJ, Collis MG, Yates MS, Bowmer CJ. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine. Br J Pharmacol 104: 1062-1068, 1991.
18. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007.
19. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633, 1994.
20. Lai EY, Martinka P, Fahling M, Mrowka R, Steege A, Gericke A, Sendeski M, Persson PB, Persson AE, Patzak A. Adenosine restores angiotensin II-induced contractions by receptor-independent enhancement of calcium sensitivity in renal arterioles. Circ Res 99: 1117-1124, 2006.
21. Lai EY, Patzak A, Persson AE, Carlström M. Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium. Acta Physiol (Oxf) 196: 435-445, 2009.
22. Lai EY, Patzak A, Steege A, Mrowka R, Brown R, Spielmann N, Persson PB, Fredholm BB, Persson AE. Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int 70: 690-698, 2006.
23. Lau C, Sudbury I, Thomson M, Howard PL, Magil AB, Cupples WA. Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes. Am J Physiol Regul Integr Comp Physiol 296: R1761-R1770, 2009.
24. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52: 691-697, 2009.
25. Morato M, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. The role of angiotensin II in hypertension due to adenosine receptors blockade. Eur J Pharmacol 455: 135-141, 2002.
26. Munger KA, Jackson EK. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Am J Physiol Renal Fluid Electrolyte Physiol 267: F783-F790, 1994.
27. Nishiyama A, Inscho EW, Navar LG. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity. Am J Physiol Renal Physiol 280: F406-F414, 2001.
28. Nordquist L, Brown R, Fasching A, Persson P, Palm F. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol Renal Physiol 297: F1265-F1272, 2009.
29. O'Donnell MP, Kasiske BL, Keane WF. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J 2: 2339-2347, 1988.
30. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61: 186-194, 2002.
31. Onozato ML, Tojo A, Leiper J, Fujita T, Palm F, Wilcox CS. Expression of NG, NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers. Diabetes 57: 172-180, 2008.
32. Osswald H. Renal effects of adenosine and their inhibition by theophylline in dogs. Naunyn Schmiedebergs Arch Pharmacol 288: 79-86, 1975.
33. Osswald H, Spielman WS, Knox FG. Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 43: 465-469, 1978.
34. Palm F, Buerk DG, Carlsson PO, Hansell P, Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 54: 3282-3287, 2005.
35. Palm F, Fasching A, Hansell P, Kallskog O. Nitric oxide originating from NOS1 controls oxygen utilization and electrolyte transport efficiency in the diabetic kidney. Am J Physiol Renal Physiol 298: F416-F420, 2010.
36. Patzak A, Lai EY, Fahling M, Sendeski M, Martinka P, Persson PB, Persson AE. Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles. Am J Physiol Regul Integr Comp Physiol 293: R2232-R2242, 2007.
37. Pawelczyk T, Grden M, Rzepko R, Sakowicz M, Szutowicz A. Regionspecific alterations of adenosine receptors expression level in kidney of diabetic rat. Am J Pathol 167: 315-325, 2005.
38. Pawlowska D, Granger JP, Knox FG. Effects of adenosine infusion into renal interstitium on renal hemodynamics. Am J Physiol Renal Fluid Electrolyte Physiol 252: F678-F682, 1987.
39. Persson P, Hansell P, Palm F. Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol (Oxf) 200: 3-10, 2010.
40. Pflueger AC, Osswald H, Knox FG. Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide. Am J Physiol Renal Physiol 276: F340-F346, 1999.
41. Pflueger AC, Schenk F, Osswald H. Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. Am J Physiol Renal Fluid Electrolyte Physiol 269: F529-F535, 1995.
42. Pihl L, Persson P, Fasching A, Hansell P, DiBona GF, Palm F. Insulin induces the correlation between renal blood flow and glomerular filtration rate in diabetes: implications for mechanisms causing hyperfiltration. Am J Physiol Regul Integr Comp Physiol 303: R39-R47, 2012.
43. Quan A, Baum M. Endogenous production of angiotensin II modulates rat proximal tubule transport. J Clin Invest 97: 2878-2882, 1996.
44. Rosivall L, Navar LG. Effects on renal hemodynamics of intra-arterial infusions of angiotensins I and II. Am J Physiol Renal Fluid Electrolyte Physiol 245: F181-F187, 1983.
45. Sallstrom J, Carlsson PO, Fredholm BB, Larsson E, Persson AE, Palm F. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 190: 253-259, 2007.
46. Schnermann J. Adenosine mediates tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol 283: R276-R279, 2002.
47. Shirley DG, Walter SJ, Sampson B. A micropuncture study of renal lithium reabsorption: effects of amiloride and furosemide. Am J Physiol Renal Fluid Electrolyte Physiol 263: F1128-F1133, 1992.
48. Sousa T, Morato M, Albino-Teixeira A. Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. Eur J Pharmacol 441: 99-104, 2002.
49. Spielman WS, Osswald H. Blockade of postocclusive renal vasoconstriction by an angiotensin II antagonists: evidence for an angiotensin-adenosine interaction. Am J Physiol Renal Fluid Electrolyte Physiol 237: F463-F467, 1979.
50. Thomsen K, Schou M, Steiness I, Hansen HE. Lithium as an indicator of proximal sodium reabsorption. Pflügers Arch 308: 1969.
51. Vallon V. Micropuncturing the nephron. Pflügers Arch 458: 189-201, 2009.
52. Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 300: R1009-R1022, 2011.
53. Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev 86: 901-940, 2006.
54. Vallon V, Osswald H. Adenosine receptors and the kidney. Handb Exp Pharmacol 443-470, 2009.
55. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10: 2569-2576, 1999.
56. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Synergistic effects of angiotensin and adenosine in the renal microvasculature. Am J Physiol Renal Fluid Electrolyte Physiol 266: F227-F239, 1994.
57. Wilcox CS, Welch WJ, Schreiner GF, Belardinelli L. Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol 10: 714-720, 1999.
58. Zou AP, Nithipatikom K, Li PL, Cowley AW Jr. Role of renal medullary adenosine in the control of blood flow and sodium excretion. Am J Physiol Regul Integr Comp Physiol 276: R790-R798, 1999.